Clinical Trials
The Department of Neurology is actively involved in clinical trials to determine the effectiveness of new medications to treat neuromuscular diseases and disorders. If you are interested in receiving additional information or participating in a trial, please e-mail or call the persons listed below. Please note that enrollment is currently closed for some of the trials.


Movement Disorders / Parkinson's Disease - Completed Trials

A Longitudinal Observational Follow-up of the PRECEPT Study Cohort (PostCEPT)
  Enrollment is CLOSED
 
A Parkinson's Disease study that required annual visits for subjects that have completed the PreCept study.

  Principle Investigator: Un Jung Kang MD
  Study Coordinator: Joan Young, 773-834-1688


Deep Brain Stimulation for Dystonia (Compassionate IND)
  Enrollment is CLOSED
 
Patients with dystonia who are inadequately controlled by medications and other conventional treatment can be considered for deep brain stimulation

  Principle Investigator: Un Jung Kang MD
  Study Coordinator: Joan Young, 773-834-1688


Dystonia
  Enrollment is CLOSED
 
A prospective, double-blind, placebo-controlled, randomized, multi-center trial with a double-blind parallel-group extension period to investigate the efficacy and safety of different doses of NT 201 in the treatment of cervical dystonia (Mertz). This study was for subject with Cervical Dystonia.

  Principle Investigator: Un Jung Kang MD
  Study Coordinator: Joan Young, 773-834-1688


MAO-B Inhibitor for Early Parkinson's Disease
  Enrollment is CLOSED
 
Study was for patients with newly diagnosed Parkinson's Disease who are not on Sinemet.

  Principle Investigator: Un Jung Kang MD
  Study Coordinator: Barbara Clay, 773-834-1688


Neuroprotection for Early Parkinson's Disease
  Enrollment is CLOSED
 
Study was for patients with newly diagnosed Parkinson's Disease who are not on symptomatic therapy.

  Principle Investigator: Un Jung Kang MD
  Study Coordinator: Joan Young, 773-834-1688